Bluu Bioscience secured €7 million in a round backed by Manta Ray Ventures, Norrsken VC, Be8, CPT Capital and Lever VC.

Bluu Bioscience, a Berlin, Germany-based producer of alternative fish, made out of cells, announced the completion of a €7 million ($8.2M) capital funding round.

The money was raised from a range of investors including Manta Ray Ventures, Norrsken VC, Be8, CPT Capital and Lever VC.

Bluu Bioscience, founded in 2020 by CEO Sebastian Rakers and Simon Fabich, is working for the development of cell-based cultivated fish, with a focus on salmon, trout and carp. The company is still in R&D mode, and is expecting to have a prototype product out by the end of 2022.